Colorectal cancer (CRC) is one of the cancers that heavily threaten human health worldwide. At present, the lack of representative models is the main restrictive factor for the development of treatment against CRC. Based on our experienced scientific team, Creative Biolabs has established advanced 3D biology platform. As a result, we’re able to provide high-quality and customizable normal colorectal organoid models for global customers.
Differing from conventional modeling approaches, organoids are micro-organs cultured in vitro, which have the capacity to self-renew and differentiate. Normal colorectal organoid models are generated from healthy tissues and show the following advantages.
In CRC research, organoids prove their superiority in studying intestinal homeostasis and epithelial cancers. They offer the new opportunity of dissecting CRC to prevent classical limitations, for example, the difficulty of long-term culture of normal intestinal epithelial cells and the deficiency of suitable animal models for exploring the initiation and progression mechanism of CRC. Supplements for each other, the normal colorectal organoid and tumor organoid can be applied in CRC modeling, drug testing and screening, personalized treatment and regenerative medicine. They are promising to combine with emerging technologies, such as gene editing, and scRNA-seq, thus to accelerate the anti-tumor drug development and improve the treatment progress of CRC patients in the future.
Fig.1 Schematic representation of the uses of normal and tumor organoids for CRC basic and clinical research. (Barbáchano, 2021)
To date, Creative Biolabs has developed and evaluated a collection of 3D organoid models including normal colorectal organoids. Apart from extensive material repositories in response to urgent needs, we also provide a series of technical services listed below. If you have any CRC research needs, we will always be delighted to help you. Please feel free to reach out for more details.
Reference